Phase 3 clinical trial results (TRANSCEND-T2D-1) published in The Lancet report that retatrutide, an investigational ...
Online sales of unapproved peptides are booming, and patients injecting these drugs are increasingly presenting to EDs with ...
Retatrutide is a triple agonist, meaning it targets three hormone receptor agonists: GLP-1, GIP and glucagon (GCG). It’s ...
Q: Is President Trump the anonymous 79-year-old man getting a still-unapproved obesity drug via a Food and Drug ...
This was exactly what I wanted, but I wanted this over three months. But every time I looked in the mirror, my body was ...
It isn't approved by the FDA, but we found an experimental weight-loss drug called retatrutide for sale at a local ...
The buzz around weight-loss drugs has never been louder or more exciting, especially when it comes to a brand new option ...
The rumor stems from a report claiming an unnamed 79-year-old man received access to the drug earlier this year.
In the realm of weight loss medications, retatrutide weight loss is making headlines as an experimental drug that offers a glimmer of hope for individuals grappling with obesity and related health ...